140 related articles for article (PubMed ID: 37481941)
21. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
Wang L; Park P; Zhang H; La Marca F; Lin CY
Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
[TBL] [Abstract][Full Text] [Related]
22. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
23. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p.
Han Q; Yang J; Yang H; Li C; Li J; Cao Y
Cell Cycle; 2020 May; 19(10):1172-1185. PubMed ID: 32286148
[No Abstract] [Full Text] [Related]
24. Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B.
Mizushima E; Tsukahara T; Emori M; Murata K; Akamatsu A; Shibayama Y; Hamada S; Watanabe Y; Kaya M; Hirohashi Y; Kanaseki T; Nakatsugawa M; Kubo T; Yamashita T; Sato N; Torigoe T
Cancer Sci; 2020 Jan; 111(1):36-46. PubMed ID: 31705593
[TBL] [Abstract][Full Text] [Related]
25. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
26. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.
Cortini M; Massa A; Avnet S; Bonuccelli G; Baldini N
PLoS One; 2016; 11(11):e0166500. PubMed ID: 27851822
[TBL] [Abstract][Full Text] [Related]
28. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
29. Novel agent DMAMCL suppresses osteosarcoma growth and decreases the stemness of osteosarcoma stem cell.
Ba G; Hua Z; Xu N; Zhang S; Liu Z; Thiele CJ; Li Z
Cell Cycle; 2020 Jun; 19(12):1530-1544. PubMed ID: 32401122
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
31. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
Song XJ; Bi MC; Zhu QS; Liu XL
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
[TBL] [Abstract][Full Text] [Related]
32. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S.
Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y
J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209
[TBL] [Abstract][Full Text] [Related]
35. KLF8 promotes cancer stem cell-like phenotypes in osteosarcoma through miR-429-SOX2 signaling.
Zhang L; Yang P; Liu Q; Wang J; Yan F; Duan L; Lin F
Neoplasma; 2020 May; 67(3):519-527. PubMed ID: 32122144
[TBL] [Abstract][Full Text] [Related]
36. NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation.
Zhao T; Meng Y; Wang Y; Wang W
J Orthop Surg Res; 2021 Jun; 16(1):364. PubMed ID: 34099022
[TBL] [Abstract][Full Text] [Related]
37. Metformin increases sensitivity of osteosarcoma stem cells to cisplatin by inhibiting expression of PKM2.
Shang D; Wu J; Guo L; Xu Y; Liu L; Lu J
Int J Oncol; 2017 May; 50(5):1848-1856. PubMed ID: 28393220
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
Yan T; Zhu S; Zhang J; Lu G; Lv C; Wei Y; Luo M
Mol Med Rep; 2018 Dec; 18(6):5221-5228. PubMed ID: 30280196
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
[TBL] [Abstract][Full Text] [Related]
40. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition.
Jiang N; Wang X; Xie X; Liao Y; Liu N; Liu J; Miao N; Shen J; Peng T
Cancer Lett; 2017 Oct; 405():46-55. PubMed ID: 28642170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
